A detailed history of Family Management Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Family Management Corp holds 3,427 shares of NVO stock, worth $291,295. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,427
Previous 3,379 1.42%
Holding current value
$291,295
Previous $482,000 15.35%
% of portfolio
0.07%
Previous 0.09%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $5,715 - $6,980
48 Added 1.42%
3,427 $408,000
Q2 2024

Aug 14, 2024

BUY
$122.71 - $146.91 $3,558 - $4,260
29 Added 0.87%
3,379 $482,000
Q1 2024

May 15, 2024

SELL
$102.11 - $135.92 $204 - $271
-2 Reduced 0.06%
3,350 $430,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $2,633 - $3,163
30 Added 0.9%
3,352 $346,000
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $156,689 - $343,807
1,723 Added 107.75%
3,322 $302,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $163,977 - $216,392
1,599 New
1,599 $216,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $192B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Family Management Corp Portfolio

Follow Family Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Family Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Family Management Corp with notifications on news.